Phase I study of cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil (5-FU) in patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 5513-5513 ◽  
Author(s):  
Y. Humblet ◽  
E. Vega-Villegas ◽  
R. Mesia ◽  
A. Awada ◽  
L. Geoffrois ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Phase I Study ◽  
Metastatic Squamous Cell Carcinoma

A phase I study of erlotinib and bevacizumab for recurrent or metastatic squamous cell carcinoma of the head and neck (HNC)

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 5504-5504 ◽  
Author(s):  
E. E. Vokes ◽  
E. E. W. Cohen ◽  
A. M. Mauer ◽  
T. G. Karrison ◽  
S. J. Wong ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Phase I Study ◽  
Metastatic Squamous Cell Carcinoma
Sign in / Sign up

Export Citation Format

Share Document